Key Issues Dialogue: Albumin in Clinical Fluid Management

The Key Issues Dialogue meeting in 2013, sponsored by CSL Behring, was held to facilitate the exchange of information regarding the pros and cons of using albumin in volume replacement in complications of liver disease, in critically ill patients with a condition such as sepsis, and in cardiac surgery.

It featured experts from the medical community in the United States and Europe. Read their biographies here and view the reference list here.

The views and opinions expressed in this Key Issues Dialogue are those of the participants and do not necessarily reflect the official policy or position of CSL Behring.

Key discussions

Login/ Register Maximise Minimise